Literature DB >> 29098434

Resection outcomes and recurrence rates of endoscopic submucosal dissection (ESD) and hybrid ESD for colorectal tumors in a single Italian center.

Reza V Milano1, Edi Viale2, Michael J Bartel3, Chiara Notaristefano2, Pier Alberto Testoni2.   

Abstract

BACKGROUND: Endoscopic submucosal dissection (ESD) and hybrid-ESD techniques are treatment modalities for colorectal neoplasia, although mostly used in the Eastern hemisphere. Only few data on ESD for colorectal neoplasia have been published in the West. We report the outcomes of colorectal ESD and hybrid ESD in a single Italian center.
METHODS: We retrospectively evaluated the outcomes of all ESD and hybrid-ESD procedures for colorectal neoplasia performed over the first 2-year experience from a prospectively recorded database. Neuroendocrine tumors and adenocarcinoma with submucosal infiltration through the submucosal (SM) 2 layer or deeper were excluded. The primary outcome was the recurrence rate at the 6- to 12-month follow-up.
RESULTS: Fifty-two patients were included in the study, of which 23 underwent ESD and 29 hybrid ESD. The mean lesion sizes for ESD and hybrid ESD were similar (25.8 vs. 25.4 mm, p = 0.940), while median procedure length was significantly longer for ESD (120 vs. 60 min, p < 0.001). ESD and hybrid ESD yielded similar en-bloc resection rate (82.6 vs. 82.8%) and R0 resection rate (34.8 vs. 31%). ESD had a lower neoplasia recurrence rate than hybrid ESD (11.7 vs. 20%) and a lower bleeding rate (0 vs. 8.7%). One perforation occurred in the hybrid-ESD cohort and two perforations in the ESD cohort, of which one required surgical intervention. Non-recurrence at follow-up was associated with R0 status, en-bloc resection, and lesion size ≤ 20 mm.
CONCLUSION: Our outcomes are comparable with other studies in Western series. Studies addressing the cost effectiveness of ESD and comparing its long-term outcome with endoscopic mucosal resection in the West are needed.

Entities:  

Keywords:  Colorectal; ESD; Endoscopic submucosal dissection; Hybrid ESD; Italian center; Western center

Mesh:

Year:  2017        PMID: 29098434     DOI: 10.1007/s00464-017-5928-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  19 in total

Review 1.  The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.

Authors: 
Journal:  Gastrointest Endosc       Date:  2003-12       Impact factor: 9.427

Review 2.  Endoscopic submucosal dissection (ESD) versus simplified/hybrid ESD.

Authors:  Takashi Toyonaga; Mariko Man-I; Yoshinori Morita; Takeshi Azuma
Journal:  Gastrointest Endosc Clin N Am       Date:  2014-01-25

Review 3.  Management of colorectal T1 carcinoma treated by endoscopic resection from the Western perspective.

Authors:  Michael J Bartel; Bhaumik S Brahmbhatt; Michael B Wallace
Journal:  Dig Endosc       Date:  2016-02-16       Impact factor: 7.559

4.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

5.  Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center.

Authors:  A Probst; D Golger; M Anthuber; B Märkl; H Messmann
Journal:  Endoscopy       Date:  2012-04-23       Impact factor: 10.093

6.  Colorectal tumours and pit pattern.

Authors:  S Kudo; S Hirota; T Nakajima; S Hosobe; H Kusaka; T Kobayashi; M Himori; A Yagyuu
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection.

Authors:  Yutaka Saito; Masakatsu Fukuzawa; Takahisa Matsuda; Shusei Fukunaga; Taku Sakamoto; Toshio Uraoka; Takeshi Nakajima; Hisatomo Ikehara; Kuang-I Fu; Takao Itoi; Takahiro Fujii
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

8.  Optimized hybrid endoscopic submucosal dissection for colorectal tumors: a randomized controlled trial.

Authors:  Jung Ho Bae; Dong-Hoon Yang; Seungyun Lee; Jae Seung Soh; Seohyun Lee; Ho-Su Lee; Hyo Jeong Lee; Sang Hyoung Park; Kyung-Jo Kim; Byong Duk Ye; Seung-Jae Myung; Suk-Kyun Yang; Jeong-Sik Byeon
Journal:  Gastrointest Endosc       Date:  2015-08-28       Impact factor: 9.427

9.  Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan.

Authors:  Takeshi Nakajima; Yutaka Saito; Shinji Tanaka; Hiroyasu Iishi; Shin-ei Kudo; Hiroaki Ikematsu; Masahiro Igarashi; Yuusuke Saitoh; Yuji Inoue; Kiyonori Kobayashi; Takashi Hisasbe; Takahisa Matsuda; Hideki Ishikawa; Ken-ichi Sugihara
Journal:  Surg Endosc       Date:  2013-03-19       Impact factor: 4.584

10.  Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.

Authors:  Andrew M Veitch; Geoffroy Vanbiervliet; Anthony H Gershlick; Christian Boustiere; Trevor P Baglin; Lesley-Ann Smith; Franco Radaelli; Evelyn Knight; Ian M Gralnek; Cesare Hassan; Jean-Marc Dumonceau
Journal:  Gut       Date:  2016-03       Impact factor: 23.059

View more
  1 in total

1.  Efficacy and safety of hybrid endoscopic submucosal dissection compared with endoscopic submucosal dissection for rectal neuroendocrine tumors and risk factors associated with incomplete endoscopic resection.

Authors:  Xiang-Yao Wang; Ning-Li Chai; En-Qiang Linghu; Hui-Kai Li; Ya-Qi Zhai; Xiu-Xue Feng; Wen-Gang Zhang; Jia-Le Zou; Long-Song Li; Jing-Yuan Xiang
Journal:  Ann Transl Med       Date:  2020-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.